Teva Pharmaceutical (TEVA) Stock Rating Cut at HSBC

NEW YORK (TheStreet) -- Teva Pharmaceutical Industries (TEVA) stock was downgraded to "hold" from "buy" at HSBC on Friday morning, the Fly reports.

The firm also slashed its price target to $44 from $64 on shares of the Israel-based pharmaceutical company.

HSBC assigned a higher discount rate due to the significant uncertainty stemming from the U.S. Department of Justice's investigation into generic drug makers, the Fly noted.

The DOJ may file charges in a probe of about a dozen generic drug companies by the end of the year, according to Bloomberg.

The firm did not change its Teva estimates.

Shares of Teva were higher in pre-market trading today. The stock closed down 9.53% to $39.20 on Thursday.

Separately, TheStreet Ratings Team has a "Hold" rating with a score of C+ on the stock.

The primary factors that have impacted the rating are mixed. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins.

But the team also finds weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: TEVA

More from Markets

German Automakers Slump After Trump Tweets New Tariff Threat

German Automakers Slump After Trump Tweets New Tariff Threat

Chipotle Rises After Wedbush Lifts Price Target

Chipotle Rises After Wedbush Lifts Price Target

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s